1184986-84-2

Basic information

• Product Name: C-(5-Methyl-[1,2,4]oxadiazol-3-yl)-methylaminehydrochloride
• Synonyms: C-(5-Methyl-[1,2,4]oxadiazol-3-yl)-methylaminehydrochloride;1-(5-Methyl-1,2,4-oxadiazol-3-yl)methanamine hydrochloride;(5-Methyl-1,2,4-Oxadiazol-3-Yl)Methanamine Hydrochloride
• CAS NO: 1184986-84-2
• Molecular Formula: C4H8ClN3O
• Molecular Weight: 149.57882
• Mol File: 1184986-84-2.mol
• Article Data: 0

Chemical Properties

• Appearance: /
• Storage Temp.: under inert gas (nitrogen or Argon) at 2-8°C
• CAS DataBase Reference: C-(5-Methyl-[1,2,4]oxadiazol-3-yl)-methylaminehydrochloride(CAS DataBase Reference)
• NIST Chemistry Reference: C-(5-Methyl-[1,2,4]oxadiazol-3-yl)-methylaminehydrochloride(1184986-84-2)
• EPA Substance Registry System: C-(5-Methyl-[1,2,4]oxadiazol-3-yl)-methylaminehydrochloride(1184986-84-2)

Safety Data

• Hazard Codes: Xi,Xn
• Statements: 22
• HazardClass: IRRITANT
• Hazardous Substances Data: 1184986-84-2(Hazardous Substances Data)

Usage

Description

C-(5-Methyl-[1,2,4]oxadiazol-3-yl)-methylaminehydrochloride, also known as CX516, is a chemical compound belonging to the class of ampakines. These compounds modulate the activity of the AMPA receptor in the brain, which is crucial for synaptic transmission and cognitive functions. CX516 has been studied for its potential cognitive-enhancing and neuroprotective effects, with the ability to improve memory and learning abilities. It is believed to enhance synaptic transmission and promote the formation of long-term potentiation in the brain, which are key processes underlying learning and memory.

Uses

Used in Pharmaceutical Industry:
C-(5-Methyl-[1,2,4]oxadiazol-3-yl)-methylaminehydrochloride is used as a cognitive enhancer for its potential to improve memory and learning abilities. Its mechanism of action involves modulation of the AMPA receptor, leading to enhanced synaptic transmission and the promotion of long-term potentiation in the brain.
Used in Neuroprotective Applications:
CX516 is used as a neuroprotective agent due to its potential to protect neurons from damage and degeneration. This makes it a candidate for therapeutic applications in conditions characterized by neuronal loss, such as Alzheimer's disease and age-related cognitive decline.
Used in Alzheimer's Disease Treatment:
C-(5-Methyl-[1,2,4]oxadiazol-3-yl)-methylaminehydrochloride is used as a potential therapeutic agent for Alzheimer's disease. Its neuroprotective properties and ability to enhance cognitive functions make it a promising candidate for treating or slowing the progression of this neurodegenerative condition.
Used in Age-Related Cognitive Decline:
CX516 is used as a potential treatment for age-related cognitive decline, aiming to improve memory and learning abilities in elderly individuals. Its cognitive-enhancing effects may help counteract the decline in cognitive functions associated with aging.